Forum Topics PIQ PIQ PromarkerD Commercialisation
Bradbury
Added 3 years ago

Hi @slymeat, your straw about PIQs latest investor presentation is fairly bullish on how the company is setup for 2022. I have been a holder for awhile now IRL so I am hopeful that this is the year it all works out for them, however I'd like to hear if there are any key indicators that will be a deal breaker for you. The reason is PIQ have been in a holding pattern with distribution in Italy and Israel for some time now. The below is from an investor presentation in Nov 2020. LINK

04988a3b3f6723ce5df50ab4cc6c32a7c42178.jpeg

It's been a tough time for healthcare companies in the midst of a global pandemic, but at some point they need to start delivering. The other risk I see here is these are 2 year agreements that so far haven't delivered for either party, so there is a chance that if the end of the year rolls around they may not be renewed.

I think the product is very beneficial, particularly if they can get approval for the Endometriosis test that is in the works. One of my main issues as a relatively new investor is that I get caught up in the story and have been caught up in a few companies now where management keep making promises that they continue to miss. I am working through how I evaluate this for myself, and know that you hold some blue sky companies and am interested to hear what your process is for setting checkpoints for your thesis.

Cheers

12

CanadianAussie
Added 3 years ago

Great point @Bradbury


I too hold PIQ but my concerns are similar to yours. Management loves to tell a story/over promise and have been for many years but have failed to execute.


Someone pointed out on an alternate forum that there already exists a comparable test for Endometriosis by a competitor. As a result, I don't place much additional value to the company on this IP.

15